Back to Search
Start Over
Al-Ahliyya Amman University Researchers Update Understanding of Cancer [Cytotoxic Evaluation of Doxorubicin Combination with Baicalein and Resveratrol Against Hct116 and Hepg2 Cancer Cell Lines (Conference Paper) #].
- Source :
- Cancer Weekly; 3/14/2023, p69-69, 1p
- Publication Year :
- 2023
-
Abstract
- Keywords: Antibiotics; Antineoplastics; Cancer; Cell Line; Doxorubicin Therapy; Drugs and Therapies; Health and Medicine; Oncology; Pharmaceuticals EN Antibiotics Antineoplastics Cancer Cell Line Doxorubicin Therapy Drugs and Therapies Health and Medicine Oncology Pharmaceuticals 69 69 1 03/23/23 20230314 NES 230314 2023 MAR 14 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Fresh data on cancer are presented in a new report. The combination of doxorubicin, Baicalein, and resveratrol has resulted in a less cardiotoxic effect compared to treatment with doxorubicin alone." Conclusion: combinations of Baicalein and resveratrol with doxorubicin chemotherapeutic drug In Vitro had enhanced the cytotoxic activity of such a chemotherapeutic drug, while simultaneously eliminating its cardio-toxicity side effect.". [Extracted from the article]
- Subjects :
- CELL lines
DOXORUBICIN
CANCER cells
RESVERATROL
CONFERENCE papers
Subjects
Details
- Language :
- English
- ISSN :
- 10717218
- Database :
- Complementary Index
- Journal :
- Cancer Weekly
- Publication Type :
- Periodical
- Accession number :
- 162555008